Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection?
about
Interventions for preventing oral mucositis for patients with cancer receiving treatmentInterventions for preventing oral mucositis for patients with cancer receiving treatmentInterventions for preventing oral mucositis for patients with cancer receiving treatmentInterventions for preventing oral mucositis for patients with cancer receiving treatmentEffect of amifostine in head and neck cancer patients treated with radiotherapy: a systematic review and meta-analysis based on randomized controlled trialsComparison of acute toxicities in two primary chemoradiation regimens in the treatment of advanced head and neck squamous cell carcinoma.Efficacy and tolerability of amifostine in elderly cancer patientsChemotherapy-induced and/or radiation therapy-induced oral mucositis--complicating the treatment of cancer.Commentary: the pharmacological antioxidant amifostine -- implications of recent research for integrative cancer care.Amifostine in the management of radiation-induced and chemo-induced mucositis.Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses.Post-radiation dental index: development and reliabilityA systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact.The effect of amifostine on submandibular gland histology after radiation.Systematic review of amifostine for the management of oral mucositis in cancer patients.Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy.Prospective investigation and literature review of tolerance dose on salivary glands using quantitative salivary gland scintigraphy in the intensity-modulated radiotherapy era.Selenoprotein P inhibits radiation-induced late reactive oxygen species accumulation and normal cell injury.Daily subcutaneous amifostine administration during irradiation of pediatric head and neck cancers.
P2860
Q24235217-DE43610A-D01B-476E-BFE0-AB209590FA13Q24235482-EA47C19D-AE5F-4E02-AD1D-E663932A296BQ24243046-4DD466BF-45A8-4DBC-95FA-4D99E6C43A74Q24246310-4A8E5098-CF60-4C39-9ADF-E61C08609950Q28538411-C78AE2AE-482C-4EE8-AD9D-EFB3D6A4580AQ33399402-95E0BF6C-C00B-4358-AB4A-7E3EC5BDB598Q33738758-A9205B45-9DEA-4D3B-8B13-3F0CCC05D762Q34928237-55A15177-F3C5-4FC5-B085-5A971C53A9AAQ36390553-5134B05C-CE96-4C4F-9631-68BD1797BA4DQ36439731-0E2A9C2F-C6AC-407A-9E08-E12245FFC93DQ36544184-F7E2137F-1ADC-4CE3-8982-578722D4C3D9Q37259248-4E758285-EA9D-4D63-B085-07B763168A62Q37718044-E8ED2DC9-5A17-4E3A-9242-2D248DB0FAB6Q38030528-7ADFD034-4430-4EB5-AA15-029312A40852Q38050986-F8E808BD-3C64-4B6A-B716-758AA3CCD8E5Q38651513-0DFC7179-EE4E-41E3-8671-ACFABECB99E7Q38733003-4E5D6E55-0127-41F0-B9F0-2080B417C24FQ42962084-67C1595C-BFA3-4902-AB67-BA049D5D3121Q46881532-4C1871A6-0B75-4C18-8DAB-88742F572A38
P2860
Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection?
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Randomized phase III trial of ...... evidence for radioprotection?
@en
Randomized phase III trial of ...... evidence for radioprotection?
@nl
type
label
Randomized phase III trial of ...... evidence for radioprotection?
@en
Randomized phase III trial of ...... evidence for radioprotection?
@nl
prefLabel
Randomized phase III trial of ...... evidence for radioprotection?
@en
Randomized phase III trial of ...... evidence for radioprotection?
@nl
P2093
P1476
Randomized phase III trial of ...... evidence for radioprotection?
@en
P2093
Axel Hinke
Birgit Mahlmann
Eckart Richter
Fabian Fehlauer
Konrad Sommer
Meinolf Marx
Peter Vacha
Thomas Feyerabend
P2888
P304
P356
10.1007/S00066-003-1016-1
P577
2003-06-01T00:00:00Z